Stephanie Amiel discusses the outcomes of the HARPdoc randomized trial and explains why the intervention could be so powerful for people with type 1 diabetes and reduced hypoglycemia awareness (4:12).
01-10-2021 | EASD 2021 | Conference coverage | Video